Journals / Turkish Journal of Anaesthesiology and Reanimation / 2022 / Cilt: 50 - Sayı: 1

Comparison of Venti lator -Asso ciate d Pneumonia in Patients Admitted to Intensive Care for COVID-19 Versus Other Reasons: A Single-Centered Study

Pages
S22–S28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The predictive value of fever in the diagnosis is very low, and agent production together with increased purulent sputum will be more valuable in terms of diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: COVID-19 patients in intensive care usually need invasive mechanical ventilation due to advanced respiratory failure.
📊
Key Findings & Data:This study evaluates the frequency, clinical features, causative pathogens, and outcomes of venti lator -asso ciate d pneumonia in COVID-19 patients who require mechanical ventilation.
💡
Conclusion & Impact:The predictive value of fever in the diagnosis is very low, and agent production together with increased purulent sputum will be more valuable in terms of diagnosis.
🔬Design:Review & Systematic Survey
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: COVID-19 patients in intensive care usually need invasive mechanical ventilation due to advanced respiratory failure. Deep lymphopenia, immunosuppressive agents, long-term mechanical ventilation, and sedation may lead to venti lator -asso ciate d pneumonia; an important cause of morbidity and mortality. This study evaluates the frequency, clinical features, causative pathogens, and outcomes of venti lator -asso ciate d pneumonia in COVID-19 patients who require mechanical ventilation. Methods: The files of patients hospitalized in our hospital’s intensive care clinic between March 25, 2020, and January 15, 2021, in the first 2 peaks due to COVID-19 and other reasons were retrospectively reviewed. Results: We found venti lator -asso ciate d pneumonia rate in COVID-19 patients as 52.2%, which was statistically significantly higher than in non-COVID patients (33.5%). Purulent sputum, leukocyte, and procalcitonin levels were found to be significantly higher in both groups developing venti lator -asso ciate d pneumonia. However, fever levels were found to be significantly normal in both groups; 97.1% and 87%, respectively. High fever was observed in only 2.9% of COVID-19 patients who developed venti lator -asso ciate d pneumonia. We determined a mortality rate of 17 (100%) in the diabetes patients in the COVID-19 group, which was statistically significantly higher than in non-COVID-19 patients at 9 (64.3%). The mortality rate (86.1%) in those with COVID-19 was statistically significantly higher than in those without COVID-19 (64.9%). Conclusions: Venti lator -asso ciate d pneumonia is more common in COVID-19 patients treated with mechanical ventilation than in non- COVID patients. The predictive value of fever in the diagnosis is very low, and agent production together with increased purulent sputum will be more valuable in terms of diagnosis.

🔖

Cite This Article

SARI, A., AKÇA, H., AKMAN, D., İNAN, A., KAYMAKÇI, A., EKİNCİ, O. (2022). Comparison of Venti lator -Asso ciate d Pneumonia in Patients Admitted to Intensive Care for COVID-19 Versus Other Reasons: A Single-Centered Study. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 50 - Sayı: 1, S22–S28. https://ajindex.com/articles/418255

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bassetti M, Giacobbe DR, Aliberti S, et al. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020
  2. 26(7):880-894. [CrossRef] 2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020
  3. 382(8):727-733. [CrossRef] 3. François B, Laterre PF, Luyt CE, Chastre J. The challenge of venti lator -asso ciate d pneumonia diagnosis in COVID-19 patients. Crit Care. 2020
  4. 24(1):289. [CrossRef] 4. Robba C, Battaglini D, Pelosi P, Rocco PRM. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020
  5. 14(9):865-868. [CrossRef] 5. Luyt CE, Sahnoun T, Gautier M, et al. Venti lator -asso ciate d pneumonia in patients with SARS- CoV-2 -asso ciate d acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care. 2020
  6. 10(1):158. [CrossRef] 6. Craven DE, Hudcova J, Lei Y. Diagnosis of venti lator -asso ciate d respiratory infections (VARI): microbiologic clues for trachea bronchitis (VAT) and pneumonia (VAP). Clin Chest Med. 2011
  7. 32(3):547-557. [CrossRef] 7. Rouzé A, Martin-Loeches I, Povoa P, et al. Relationship between SARS-CoV-2 infection and the incidence of venti lator -asso ciate d lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021
  8. 47(2):188-198. [CrossRef] 8. Razazi K, Arrestier R, Haudebourg AF, et al. Risks of venti lator -asso ciate d pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to coronavirus 19 disease. Crit Care. 2020
  9. 24(1):699. [CrossRef] 9. Ippolito M, Misseri G, Catalisano G, et al. Venti lator -asso ciate d pneumonia in patients with COVID-19: a systematic review and meta-analysis. Antibiotics (Basel). 2021
  10. 10(5):545. [CrossRef] 10. Giacobbe DR, Battaglini D, Enrile EM, et al. Incidence and prognosis of venti lator -asso ciate d pneumonia in critically ill patients with COVID-19: A multicenter study. J Clin Med. 2021
  11. 10(4):555. [CrossRef] 11. Nseir S, Martin-Loeches I, Povoa P, et al. Relationship between venti lator -asso ciate d pneumonia and mortality in COVID-19 patients: A planned ancillary analysis of the coVAPid cohort. Crit Care. 2021
  12. 25(1):177. [CrossRef] 12. Rouyer M, Strazzulla A, Youbong T, et al. Venti lator -asso ciate d pneumonia i